Request Trial

Biotech news

Reset all filters
Geography
Company
Refine search
HDT Bio and Emcure resolve $950m trade secrets 'misunderstanding'
Americas
HDT Bio and Emcure resolve $950m trade secrets 'misunderstanding'
US and Indian firms reach agreement to settle US litigation and UK arbitration | HDT had accused Emcure of trade secrets theft over COVID-19 vaccine technology.   28 May 2024
US court dismisses COVID-19 vaccine suit against Genevant, Arbutus
Biotech
US court dismisses COVID-19 vaccine suit against Genevant, Arbutus
New Jersey federal judge said Acuitas had failed to show case or controversy | Acuitas had sought declaratory judgment that Pfizer’s Comirnaty vaccine did not infringe patents.   23 May 2024
USPTO appeals panel cements key claims position in antibody case
Biotech
USPTO appeals panel cements key claims position in antibody case
ARP maintained rejection of two claims of Xencor’s antibodies patent application | Panel clarified specification for means-plus-function claim limitations.   21 May 2024
Biotech
Moderna prevails in COVID-19 vaccine row at EPO
Despite attempts by Pfizer and BioNTech to invalidate the patent, the ruling strengthens Moderna’s position in ongoing global litigation | Pfizer is considering an appeal, while BioNTech remains steadfast in defending its innovations.   21 May 2024
Biotech
Fed Circ rejects COVID-19 swabs case
Puritan Medical argued it had immunity under PREP Act in patent suit | Fed Circ said the district court had not conclusively determined any issue.   16 May 2024
Europe
NanoString buyer claims ‘win for science’ as German court invalidates 10x patent
Biotech firm to ask Munich court to permanently lift injunction on CosMx products following ruling | Judgment comes a day after acquisition by Bruker was finalised.   9 May 2024
Americas
Boston to host biggest LSPN North America–Spring Conference
Two-day event in Boston brings together leading in-house patent counsel | Regeneron, USPTO, the Broad Institute and Novartis among attendees I Agenda includes the UPC, patent strategies, and multijurisdictional patent litigation | Registrations for LSPN Fall now open.   7 May 2024
Biotech
BioNTech’s patent counsel on fostering groundbreaking innovation
Ahead of her panel discussion at LSPN North America, BioNTech’s patent counsel, shares insights into her role and ensuring innovations meet the criteria of novelty and nonobviousness.   2 May 2024
Careers
USPTO veteran joins Finnegan as of counsel in Washington, DC
Former senior legal advisor at USPTO brings wealth of life sciences experience | Move represents transition back into private practice after two decades.   2 May 2024
Biotech
CureVac and Acuitas wind up COVID-19 vaccine dispute
Settlement comes after Acuitas alleged CureVac deliberately omitted its scientists as inventors on four US patents related to COVID-19 vaccines, claiming co-inventorship | Patents in suit relate to ongoing litigation with Pfizer and BioNTech.   30 April 2024